Link to the FDA public meeting on HD and Parkinson’s Disease patient focused drug development held last week. Recordings and transcripts of the four sessions, HD is the subject of the first two sessions, are included in the link




ucm451807.htm

I think this is the full link:

[www.fda.gov]